Premium
2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy
Author(s) -
Cimino Sara,
Maestrini Viviana,
Cantisani Donatella,
Petronilli Valentina,
Filomena Domenico,
Gatto Maria C.,
Birtolo Lucia I.,
Piro Agostino,
Lavalle Carlo,
Agati Luciano
Publication year - 2019
Publication title -
echocardiography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 62
eISSN - 1540-8175
pISSN - 0742-2822
DOI - 10.1111/echo.14425
Subject(s) - cardiac resynchronization therapy , cardiology , medicine , ejection fraction , ventricle , heart failure , diastole , ventricular remodeling , dilated cardiomyopathy , cardiomyopathy , blood pressure
Purpose To describe clinical and echocardiographic characteristics associated with reverse left ventricular (LV) remodeling after 6 months of cardiac resynchronization therapy (CRT) in patients with nonischemic dilated cardiomyopathy. Methods Twenty‐four consecutive patients underwent 2D and 3D echocardiography before and after 6 months of CRT implant. Several echocardiographic parameters including global longitudinal strain (GLS) and 3D mechanical dyssynchrony (MD) index were calculated. CRT response was defined as a decrease in LV end‐systolic volume (LVESV) of at least 10% at follow‐up. Patients were divided in two groups according to CRT response. Results Cardiac resynchronization therapy responder (CRTR+) rate was 50%. Nonresponder (CRTR−) patients showed a less significant improvement in NYHA class at follow‐up. At baseline, CRTR− presented with higher LV end‐diastolic volume (LVEDV) ( P = 0.031), LVESV ( P = 0.024), lower left ventricular ejection fraction (LVEF) ( P = 0.002) and less negative GLS ( P = 0.03), and with higher diastolic dysfunction, more impaired right ventricle (RV), and higher pulmonary artery systolic pressure (PASP) ( P = 0.002). No significant differences in echocardiographic parameters of MD were found. Univariate determinants of CRTR+ were LVEF (OR = 1.59, CI 95% = 1.13–2.22, P = 0.007) and TAPSE (OR 1.21, CI 95% = 1.024–1.429, P = 0.025). A ROC curve analysis showed a cutoff value of LVEF of 22.15% significantly related to CRTR+ (SE 80%, SP 50%). Conclusions Our findings suggest that end‐stage HF patients, presenting before CRT with LVEF <22.15%, may not benefit from the procedure after 6 months. Mechanical dyssyncronicity did not provide additional information to improve candidate selection.